Eikon Therapeutics, Inc.
EIKN
DELAYED 1 MONTH
7 insider filings · Latest: Mar 2, 2026
Common Stock Transactions
No transactions found.
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Mar 2, 2026 | Mar 4 10:04 PM | Michael A KlobucharChief Operating Officer | Grant/Award | 87,157 | $14.88 | 87,157(D) | View → |
| Mar 2, 2026 | Mar 4 10:02 PM | Robert Luther HuffinesDirector | Grant/Award | 25,873 | $14.88 | 25,873(D) | View → |
| Mar 2, 2026 | Mar 4 10:01 PM | Kenneth C FrazierDirector | Grant/Award | 25,873 | $14.88 | 25,873(D) | View → |
| Mar 2, 2026 | Mar 4 10:00 PM | Roger M PerlmutterDirector, Chief Executive Officer and Director | Grant/Award | 268,176 | $14.88 | 268,176(D) | View → |
| Mar 2, 2026 | Mar 4 9:59 PM | Benjamin Bruno ThornerGeneral Counsel and Chief Business Officer | Grant/Award | 67,044 | $14.88 | 67,044(D) | View → |
| Mar 2, 2026 | Mar 4 9:59 PM | Roy D. BaynesChief Medical Officer | Grant/Award | 134,088 | $14.88 | 134,088(D) | View → |
| Mar 2, 2026 | Mar 4 9:58 PM | Alfred Lloyd Bowie Jr.Chief Financial Officer | Grant/Award | 67,044 | $14.88 | 67,044(D) | View → |